HW
CALA

Hancock Whitney’s Calithera Biosciences, Inc CALA Stock Holding History

Hancock Whitney’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,141
Closed -$79K – 860
2020
Q3 		$79K Hold
1,141
– – ﹤0.01% 770
2020
Q2 		$121K Buy
+1,141
New +$136K ﹤0.01% 745

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Hancock Whitney's CALA Position: Q4 2020 in Review

Hancock Whitney sold out of Calithera Biosciences, Inc (CALA) in Q4 2020, closing a stake of 1,141 shares — an estimated $79K sold.

Hancock Whitney first reported a position in CALA in Q2 2020 and held it in 2 quarters. The position peaked at $121K in Q2 2020. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Hancock Whitney reported no remaining Calithera Biosciences, Inc position as of Q4 2020 after selling out during the quarter.
  • Hancock Whitney sold 1,141 Calithera Biosciences, Inc shares in Q4 2020, an estimated $79K.
  • Hancock Whitney first reported a position in Calithera Biosciences, Inc in Q2 2020 and held it in 2 quarters.
  • Hancock Whitney's Calithera Biosciences, Inc position peaked at $121K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Hancock Whitney's 13F filing for Q4 2020, filed 9 Feb 2021.